Synapse - Gunjan Shah

Results (418)

Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT

Meeting Abstract

Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Toxicity analysis of propylene glycol-free melphalan (Evomela®) compared to propylene glycol-based melphalan hydrochloride in autologous hematopoietic cell transplantation for multiple myeloma

Meeting Abstract

DeRespiris, L.; Bhatt, V.; Lin, A.; Maloy, M. A.; Chung, D. J.; Landau, H.; Scordo, M.; Giralt, S. A.; Shah, G. L.
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Long term outcomes of high dose therapy and autologous hematopoietic cell transplant for lymphoplasmacytic lymphoma-associated systemic amyloidosis

Meeting Abstract

Bal, S.; Shah, G. L.; Hassoun, H.; Palomba, M. L.; Giralt, S. A.; Landau, H.
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma

Meeting Abstract

Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Medicare patients receiving chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma: A first real-world look at patient characteristics, healthcare utilization and costs

Meeting Abstract

Kilgore, K. M.; Mohammadi, I.; Schroeder, A.; Teigland, C.; Purdum, A.; Shah, G. L.
Blood (2019)

Fulltext@MSK | Save

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study

Meeting Abstract

Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
Blood (2019)

Fulltext@MSK | Save

Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation - A single institution pilot study

Research Letter

Lin, R. J.; Dahi, P. B.; Shahrokni, A.; Sarraf, S.; Korc-Grodzicki, B.; Devlin, S. M.; Maloy, M. A.; Shah, G. L.; Jakubowski, A. A.; Giralt, S. A.
Leukemia and Lymphoma (2019)

Fulltext@MSK | Save

Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)